Bangalore, India, January 27, 2010 -- Jubilant Biosys Ltd., a subsidiary of Jubilant Organosys Ltd., and Endo Pharmaceuticals (Nasdaq: ENDP)., of Chadds Ford, Pa., U.S.A., announced today that they have expanded their drug discovery partnership in oncology, following the successful delivery of an early stage milestone.

Jubilant Biosys Limited, based in Bangalore, an integrated Drug Discovery and Development solution provider, a subsidiary of Jubilant Organosys Ltd, headquartered in Noida, announced today that it has entered into a co-marketing agreement to provide screening solutions, with DiscoveRx Corporation (Fermont, USA), a premier provider of innovative cell based assay solutions for GPCR, Kinases, NHR and Proteases.

Hari S Bhartia, Co-chairman and Managing Director of Jubilant Organosys awarded person of the year at 7th Biospectrum awards 2009

Jubilant Organosys Ltd.,through its subsidiary Jubilant Biosys Ltd based in Bangalore announced today that its 4 year old research collaboration with Eli Lilly & Company, has successfully delivered multiple discovery milestones and preclinical candidates, resulting in a five-year extension and an expanded portfolio collaboration. 

BIRMINGHAM, Ala. USA/ Noida (UP) India.Nov. 23, 2009.Jubilant Organosys, the University of Alabama at Birmingham (UAB), and Southern Research Institute today announced a joint venture that will focus on leveraging their collective innovation and enabling technologies in the areas of Oncology, Metabolic Disease and Infectious Diseases. It is a unique U.S-India arbitraged and leveraged partnership that will accelerate the development of affordable therapies for patients worldwide. A Memorandum of Understanding was signed today in Washington, DC.

Duke University and Jubilant Organosys Limited, the largest integrated Custom Research and Manufacturing Services (CRAMS) and leading Drug Discovery and Development Services (DDDS) company in India, through its subsidiary, Jubilant Biosys Limited, today signed a Letter of Intent to develop a multi-faceted partnership that will expedite translation of discoveries by Duke scientists into clinical therapies. The proposed partnership will also advance both organizations' mutual commitment to reducing global health disparities. The Parties shall complete definitive agreements by the first quarter of 2010.

Jubilant Organosys Ltd., headquartered in Noida, announced today that its Bangalore-based subsidiary, Jubilant Biosys Ltd., has entered into a discovery and development collaboration with Endo Pharmaceuticals, a US-based pharmaceutical company. As part of the agreement, Jubilant and Endo would collaborate initially to develop a portfolio of targets in the area of Oncology, with a focus on delivering preclinical candidates that could be selected for joint clinical development.